Bristol-Myers Squibb Company (BMY) is currently at $67.82, down $3.37 or 4.73%
–Would be lowest close since March 8, 2022, when it closed at $67.74
–On pace for largest percent decrease since April 29, 2021, when it fell 4.76%
–Currently down seven of the past eight days
–Currently down six consecutive days; down 9.97% over this period
–Longest losing streak since Aug. 4, 2022, when it fell for six straight trading days
–Worst six day stretch since the six days ending June 15, 2020, when it fell 10.16%
–Down 8.08% month-to-date; on pace for worst month since Nov. 2021, when it fell 8.17%
–Up 8.77% year-to-date
–Down 15.2% from its all-time closing high of $79.98 on June 27, 2022
–Up 0.91% from 52 weeks ago (Aug. 30, 2021), when it closed at $67.21
–Down 15.2% from its 52-week closing high of $79.98 on June 27, 2022
–Up 26.46% from its 52-week closing low of $53.63 on Nov. 30, 2021
–Traded as low as $67.65; lowest intraday level since March 8, 2022, when it hit $67.32
–Down 4.97% at today’s intraday low; largest intraday percent decrease since April 29, 2022, when it fell as much as 4.99%
–Second worst performer in the S&P 500 today
All data as of 10:06:22 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 29, 2022 10:25 ET (14:25 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Read More: Bristol-Myers Squibb Down Nearly 5%, on Pace for Largest Percent Decrease Since April